Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: A Community Doctor's Perspective on Sickle Cell Disease & Voxelotor's Potential (GBT440)

Ticker(s): GBT

Who's the expert?

Name: Dr Jeff Stillman - DO

  • Hematologist in community practice in NY.
  • Currently manages 26-30 patients with sickle cell.
  • Very familiar with the literature to date for Voxelotor 

Interview Goal
To better understand the potential of voxelator for patients in the community setting. This call will also discuss updates from ASH 2019.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.